Australia - English - Department of Health (Therapeutic Goods Administration)

air liquide healthcare pty ltd - nitric oxide, quantity: 0.0004 mol - gas, medicinal - excipient ingredients: nitrogen - vasokinox is indicated in conjunction with ventilator support and other appropriate active substances to selectively decrease pulmonary arterial pressure in patients with perioperative pulmonary hypertension in conjunction with heart surgery

Australia - English - Department of Health (Therapeutic Goods Administration)

air liquide healthcare pty ltd - carbon dioxide, quantity: 1 ml/ml - gas, medicinal - excipient ingredients: - as an anaesthetic supplement in various clinical circumstances to maintain optimum blood carbon levels, facilitate blind intubations and rapidly increase depth of anaesthesia with volatile agents. as a respiratory stimulant after apnoea or after relief of chronic respiratory obstruction. to prevent hypocapnia during hyperventilation. use in clinical and physiological investigations including use as insufflation gas.

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

dubois chemicals australia pty ltd - nonyl phenol ethoxylate; sodium hydroxide - powder - nonyl phenol ethoxylate emulsifiers & surfactants-noni active 10.0 g/kg; sodium hydroxide mineral-sodium-base active 800.0 g/kg - dairy cleanser - dairy equipment - residue, dirt in milking equipment

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

dubois chemicals australia pty ltd - sodium hydroxide - liquid - sodium hydroxide mineral-sodium-base active 395.0 g/l - dairy cleanser - dairy equipment stainless steel - deposits (ref. to label for type) | milkstone removal | protein build-up | fat deposits | milk fat | milk protein | mineral deposits | protein deposits

Australia - English - Department of Health (Therapeutic Goods Administration)

air liquide healthcare pty ltd - 46634 - airway pressure monitor, non-powered - manometer used with an oscillating positive expiratory pressure (opep) device to provide a visual indication of a patient's airway pressure.

Australia - English - Department of Health (Therapeutic Goods Administration)

coregas pty ltd - air, quantity: 100 % v/v - gas, medicinal - excipient ingredients: - this product accepted for registration/listing as 'currently supplied' at the time of commencement of the act. indications held in artg paper records. (old code)

United States - English - NLM (National Library of Medicine)

stallergenes - phleum pratense pollen (unii: 65m88rw2eg) (phleum pratense top - unii:s7pw24bx20, phleum pratense pollen - unii:65m88rw2eg), anthoxanthum odoratum pollen (unii: 2kik19r45y) (anthoxanthum odoratum pollen - unii:2kik19r45y), dactylis glomerata pollen (unii: 83n78ida7p) (dactylis glomerata pollen - unii:83n78ida7p), poa pratensis pollen (unii: scb8j7ls3t) (poa pratensis pollen - unii:scb8j7ls3t), lolium perenne pollen (unii: 4t81lb52r0) (lolium perenne pollen - unii:4t81lb52r0) - anthoxanthum odoratum pollen 100 [ir] - oralair is an allergen extract indicated as immunotherapy for the treatment of grass pollen-induced allergic rhinitis with or without conjunctivitis confirmed by positive skin test or in vitro testing for pollen-specific ige antibodies for any of the five grass species contained in this product. oralair is approved for use in persons 5 through 65 years of age. oralair is not indicated for the immediate relief of allergy symptoms. oralair is contraindicated in patients with: - severe, unstable or uncontrolled asthma - history of any severe systemic allergic reaction - history of any severe local reaction to sublingual allergen immunotherapy - a history of eosinophilic esophagitis - hypersensitivity to any of the inactive ingredients (mannitol, microcrystalline cellulose, croscarmellose sodium, colloidal anhydrous silica, magnesium stearate and lactose monohydrate) contained in this product [ see description (11) ] risk summary all pregnancies have a risk of birth defect, loss, or other adverse outcomes.

European Union - English - EMA (European Medicines Agency)

novartis europharm limited - indacaterol, glycopyrronium bromide, mometasone - asthma - drugs for obstructive airway diseases, - enerzair breezhaler is indicated as a maintenance treatment of asthma in adult patients not adequately controlled with a maintenance combination of a long acting beta2 agonist and a high dose of an inhaled corticosteroid who experienced one or more asthma exacerbations in the previous year.

United States - English - NLM (National Library of Medicine)

cenexi hsc - phleum pratense pollen (unii: 65m88rw2eg) (phleum pratense top - unii:s7pw24bx20, phleum pratense pollen - unii:65m88rw2eg), anthoxanthum odoratum pollen (unii: 2kik19r45y) (anthoxanthum odoratum pollen - unii:2kik19r45y), dactylis glomerata pollen (unii: 83n78ida7p) (dactylis glomerata pollen - unii:83n78ida7p), poa pratensis pollen (unii: scb8j7ls3t) (poa pratensis pollen - unii:scb8j7ls3t), lolium perenne pollen (unii: 4t81lb52r0) (lolium perenne pollen - unii:4t81lb52r0) - oralair is an allergen extract indicated as immunotherapy for the treatment of grass pollen-induced allergic rhinitis with or without conjunctivitis confirmed by positive skin test or in vitro testing for pollen-specific ige antibodies for any of the five grass species contained in this product. oralair is approved for use in persons 5 through 65 years of age. oralair is not indicated for the immediate relief of allergy symptoms. oralair is contraindicated in patients with: - severe, unstable or uncontrolled asthma - history of any severe systemic allergic reaction - history of any severe local reaction to sublingual allergen immunotherapy - a history of eosinophilic esophagitis - hypersensitivity to any of the inactive ingredients (mannitol, microcrystalline cellulose, croscarmellose sodium, colloidal anhydrous silica, magnesium stearate and lactose monohydrate) contained in this product [ see description (11) ] risk summary all pregnancies have a risk of birth defect, loss, or other a

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

ecolab pty ltd - non-ionic detergents; sodium hydroxide - soluble powder - non-ionic detergents emulsifiers & surfactants-noni active 9.0 g/kg; sodium hydroxide mineral-sodium-base active 800.0 g/kg - dairy cleanser - dairy equipment stainless steel | dairy plant stainless steel | building - residue, dirt in milking equipment